Development of Urinary Density Measuring Method of Endogenous MAO Activity Inhibitors ( Isatin ). Examination in Parkinson's Disease.

Japanese Journal of Clinical Pharmacology and Therapeutics - Japan
doi 10.3999/jscpt.28.467
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Japanese Society of Clinical Pharmacology and Therapeutics

Related search

A Method for Measuring Parkinson's Disease Related Temporal Irregularity in Spiral Drawings

2016English

Effects of Combined MAO-B Inhibitors and Levodopa vs. Monotherapy in Parkinson’s Disease

Frontiers in Aging Neuroscience
AgingCognitive Neuroscience
2014English

New Measuring Method of Examination of Planar Optical Waveguides

PIERS Online
2009English

Measuring Motor Complications in Clinical Trials for Early Parkinson's Disease

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2003English

Toward Peptide-Based Inhibitors as Therapies for Parkinson's Disease

Future Medicinal Chemistry
Drug DiscoveryMolecular MedicinePharmacology
2015English

Beware — The Use of Mao Inhibitors Is Increasing Again

Anaesthesia and Intensive Care
Critical CareAnesthesiologyPain MedicineIntensive Care Medicine
1979English

Development of a Validated LC- MS/MS Method for the Quantification of 19 Endogenous Asthma/Copd Potential Urinary Biomarkers

Analytica Chimica Acta
BiochemistryEnvironmental ChemistryAnalytical ChemistrySpectroscopy
2017English

Method and Device for Measuring Stability of Plant Development by Fluctuating Asymmetry of Optical Density of Leaves

2019English

Use of Cholinesterase Inhibitors Increases Initiation of Urinary Anticholinergics in Persons With Alzheimer's Disease

Journal of the American Geriatrics Society
GerontologyGeriatrics
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy